Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesSurgical specialty, surgical unit volume, and mortality after oesophageal cancer surgery
European Journal of Surgical Oncology, 06/30/09
Leigh Y et al. - In a trial to investigate the effects of surgical specialty and volume on mortality after oesophagectomy, it was shown that pts treated by general surgeons in low-volume hospitals had worse mortality outcomes than those treated by general surgeons in high-volume hospitals or by cardiothoracic surgeons. This is important because a majority of pts who underwent oesophagectomy for cancer were in this high-mortality risk group.
Methods- Hospital Episode Statistics for oesophagectomy were analyzed for cancer (n=9034 cases), linked to data from death certificates, in England from 1998 to 2003.
- After adjustment for pts' age, sex, and deprivation score, the odds ratio (OR) for death of general surgeons' (GS) pts, compared with cardiothoracic surgeons' (CTS) pts, was significantly high: 1.62 at 90 days.
- Odds ratio for high-volume GS pts was not significantly different from that for high-volume CTS pts.
- Odds ratio for low-volume GS pts vs high-volume CTS pts was significantly high: 1.72 at 30 days and 1.48 at 90 days.
Related Articles
Obesity linked to specific cancers
Internet Source, 11/05/09
Relevance Score: 97%
Screening for Cancer
MedLinePlus, 11/02/09
Relevance Score: 97%
Lung cancer: a biologically different disease in women?
Women's Health, 10/30/09
Relevance Score: 97%
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers
Journal of Clinical Oncology, 10/29/09
Relevance Score: 97%
Preventing future cancers by testing women with ovarian cancer for brca mutations
Journal of Clinical Oncology, 10/22/09
Relevance Score: 97%
Today in GI Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
A new staging system is more discriminant than conventional staging systems for unresectable hepatocellular carcinoma
Journal of Cancer Research & Clinical Oncology, 11/24/09
Pancreatic endocrine tumors: Expression profiling evidences a role for AKT-mTOR pathway
Journal of Clinical Oncology, 11/24/09
XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk
BMC Cancer, 11/20/09
Sponsor
Article Search
Sponsor
Sponsor